Skye Bioscience, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2015 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Skye Bioscience, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2015 to Q3 2024.
- Skye Bioscience, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 38.8M shares, a 393% increase year-over-year.
- Skye Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 7.01M shares, a 215% increase from 2022.
- Skye Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 2.22M shares, a 99.5% decline from 2021.
- Skye Bioscience, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 407M shares, a 75.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)